Global Med Technologies, Inc. Sustainability Profile
Global Med Technologies, Inc., often referred to as Global MedTech, is a leading provider of innovative healthcare solutions headquartered in the United States. Founded in 1999, the company has established a strong presence in the healthcare technology sector, focusing on blood and tissue management systems. With operations spanning North America and Europe, Global MedTech offers a range of core products, including advanced software solutions for blood banks and transfusion services. Their unique approach combines cutting-edge technology with a commitment to enhancing patient safety and operational efficiency. Recognised for its significant contributions to the industry, Global MedTech has achieved notable milestones, positioning itself as a trusted partner for healthcare providers. The company continues to drive advancements in medical technology, ensuring high standards of care and compliance across the sector.
DitchCarbon Score
How does Global Med Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Global Med Technologies, Inc.'s score of 27 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Global Med Technologies, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Haemonetics Corporation, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Global Med Technologies, it is important to note that emissions data and sustainability initiatives may be cascaded from Haemonetics Corporation. This relationship suggests that any climate commitments or performance metrics may align with those of Haemonetics, although specific details are not provided. As a part of the healthcare technology sector, Global Med Technologies is positioned within an industry increasingly focused on sustainability and carbon reduction. However, without specific emissions data or defined targets, the company's current climate impact remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 5,168,600 | 0,000,000 | 0,000,000 |
| Scope 2 | 22,983,160 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is Global Med Technologies, Inc.'s Industry?
How Carbon Intensive is Global Med Technologies, Inc.'s Location?
Global Med Technologies, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Global Med Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
